Abstract Background Malignant brain tumors are the cause of a disproportionate level morbidity and mortality among cancer patients, an unfortunate statistic that has remained constant for decades. Despite considerable advances in molecular characterization these tumors, targeting cells yet to produce significant treatment. An alternative strategy is target glioblastoma microenvironment, such as...